Cover Image
市場調查報告書

Mundipharma International Limited - 製品產品管線分析

Mundipharma International Limited - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 226270
出版日期 內容資訊 英文 50 Pages
訂單完成後即時交付
價格
Back to Top
Mundipharma International Limited - 製品產品管線分析 Mundipharma International Limited - Product Pipeline Review - 2014
出版日期: 2014年01月31日 內容資訊: 英文 50 Pages
簡介

Mundipharma International Limited 針對疼痛管理、腫瘍、關節風濕、呼吸器治療領域的藥劑研究開發及製造、商品化。

本報告針對Mundipharma International Limited 治療藥開發產品管線現況與各開發階段比較分析、藥劑標的、作用程制、用藥方式、分子種類分類治療藥評價、最新企業新聞與發表、後期階段與中止計畫相關情報。

Mundipharma International Limited基本情報

Mundipharma International Limited概要

  • 主要情報
  • 企業情報

Mundipharma International Limited:R&D概要

  • 主要治療範圍

Mundipharma International Limited:產品管線回顧

  • 開發階段分類產品管線製品
  • 單劑製品
  • 併用療法模式
  • 合作製品
    • 合作製品/併用療法模式

Mundipharma International Limited:產品管線製品概況

  • 最終階段產品管線製品
    • 登錄前ソ製品/併用療法模式
    • 第III期製品/併用療法模式
  • 治療階段產品管線製品
    • 第II期製品/併用療法模式
    • 第I期製品/併用療法模式
  • 初期階段產品管線製品
    • 前臨床階段製品/併用療法模式

Mundipharma International Limited:藥劑檔案

  • (fluticasone proprionate + formoterol fumarate)
  • pralatrexate
  • forodesine hydrochloride
  • NL-101

Mundipharma International Limited:產品管線分析

Mundipharma International Limited

  • 藥效分類分類
  • 標的分類
  • 用藥方式分類
  • 分子種類分類
  • 作用機制分類

Mundipharma International Limited:最近產品管線動向

Mundipharma International Limited:暫停計畫

Mundipharma International Limited:企業發表

Mundipharma International Limited:總公司與分公司所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC04658CDB

Global Market Direct's pharmaceuticals report, "Mundipharma International Limited - Product Pipeline Review - 2014" provides data on the Mundipharma International Limited's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Mundipharma International Limited's corporate website, SEC filings, investor presentations and featured press releases, both from Mundipharma International Limited and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

  • Mundipharma International Limited - Brief Mundipharma International Limited overview including business description, key information and facts, and its locations and subsidiaries.
  • Review of current pipeline of Mundipharma International Limited human therapeutic division.
  • Overview of pipeline therapeutics across various therapy areas.
  • Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • Product profiles for late stage and clinical stage products of Mundipharma International Limited with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
  • Recent updates of the Mundipharma International Limited's pipeline in the last quarter.
  • Key discontinued and dormant projects.
  • Latest news and deals relating to the products.

Reasons to buy

  • Evaluate Mundipharma International Limited's strategic position with total access to detailed information on its product pipeline.
  • Assess the growth potential of Mundipharma International Limited in its therapy areas of focus.
  • Identify new drug targets and therapeutic classes in the Mundipharma International Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
  • Exploit collaboration and partnership opportunities with Mundipharma International Limited.
  • Avoid Intellectual Property Rights related issues.
  • Explore the dormant and discontinued projects of Mundipharma International Limited and identify potential opportunities in those areas.

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Mundipharma International Limited Snapshot
    • Mundipharma International Limited Overview
    • Key Information
    • Key Facts
  • Mundipharma International Limited - Research and Development Overview
    • Key Therapeutic Areas
  • Mundipharma International Limited - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Mundipharma International Limited - Pipeline Products Glance
    • Mundipharma International Limited - Late Stage Pipeline Products
      • Pre-Registration Products/Combination Treatment Modalities
      • Phase III Products/Combination Treatment Modalities
    • Mundipharma International Limited - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Mundipharma International Limited - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Mundipharma International Limited - Drug Profiles
    • (fluticasone proprionate + formoterol fumarate)
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • pralatrexate
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • forodesine hydrochloride
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NL-101
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Mundipharma International Limited - Pipeline Analysis
    • Mundipharma International Limited - Pipeline Products by Therapeutic Class
    • Mundipharma International Limited - Pipeline Products by Target
    • Mundipharma International Limited - Pipeline Products by Route of Administration
    • Mundipharma International Limited - Pipeline Products by Molecule Type
    • Mundipharma International Limited - Pipeline Products by Mechanism of Action
  • Mundipharma International Limited - Recent Pipeline Updates
  • Mundipharma International Limited - Dormant Projects
  • Mundipharma International Limited - Company Statement
  • Mundipharma International Limited - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Mundipharma International Limited, Key Information
  • Mundipharma International Limited, Key Facts
  • Mundipharma International Limited - Pipeline by Indication, 2014
  • Mundipharma International Limited - Pipeline by Stage of Development, 2014
  • Mundipharma International Limited - Monotherapy Products in Pipeline, 2014
  • Mundipharma International Limited - Combination Treatment Modalities in Pipeline, 2014
  • Mundipharma International Limited - Partnered Products in Pipeline, 2014
  • Mundipharma International Limited - Partnered Products/ Combination Treatment Modalities, 2014
  • Mundipharma International Limited - Pre-Registration, 2014
  • Mundipharma International Limited - Phase III, 2014
  • Mundipharma International Limited - Phase II, 2014
  • Mundipharma International Limited - Phase I, 2014
  • Mundipharma International Limited - Preclinical, 2014
  • Mundipharma International Limited - Pipeline by Therapeutic Class, 2014
  • Mundipharma International Limited - Pipeline by Target, 2014
  • Mundipharma International Limited - Pipeline by Route of Administration, 2014
  • Mundipharma International Limited - Pipeline by Molecule Type, 2014
  • Mundipharma International Limited - Pipeline Products by Mechanism of Action, 2014
  • Mundipharma International Limited - Recent Pipeline Updates, 2014
  • Mundipharma International Limited - Dormant Developmental Projects,2014
  • Mundipharma International Limited, Other Locations
  • Mundipharma International Limited, Subsidiaries

List of Figures

  • Mundipharma International Limited - Pipeline by Top 10 Indication, 2014
  • Mundipharma International Limited - Pipeline by Stage of Development, 2014
  • Mundipharma International Limited - Monotherapy Products in Pipeline, 2014
  • Mundipharma International Limited - Combination Treatment Modalities in Pipeline, 2014
  • Mundipharma International Limited - Partnered Products in Pipeline, 2014
  • Mundipharma International Limited - Pipeline by Top 10 Therapeutic Class, 2014
  • Mundipharma International Limited - Pipeline by Top 10 Target, 2014
  • Mundipharma International Limited - Pipeline by Top 10 Route of Administration, 2014
  • Mundipharma International Limited - Pipeline by Top 10 Molecule Type, 2014
  • Mundipharma International Limited - Pipeline Products by Top 10 Mechanism of Action, 2014
Back to Top